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ABSTRACT
Introduction: Oral microbiota has been implicated on oral mucositis (OM) that occurs during cancer therapy, 
however without consensus. Objective: This study, aimed to establish, through a review, the association between 
oral microbiota and OM at head and neck cancer therapy (HNCT). Material and Methods: The search of PubMed was 
performed considering 2008-2018 period, and the descriptors “oral mucositis” and “oral microbiota” in subheadings 
etiology and microbiology into the Medical Subject Heading (MeSH) “Head and Neck Neoplasms”. The conducting 
question was “Is there an oral dysbiosis during HNCT associated with OM?” Results: 22 articles were selected under 
two steps of data extraction: articles that evaluated de oral microbiota during HNCT (n=13), and articles that also 
focused in OM (n=9). Conclusion: The evidence presented in the literature suggests associations of oral microbiota 
dysbiosis with the progression and worsening of radiation-induced OM. However, to define a microbial core for the 
disease, future standardized studies are required.
Key-words: Stomatites; Oral Microbiota; Head and Neck Neoplams.
RESUMO
Introdução: A microbiota bucal tem sido associada à mucosite oral que ocorre durante a terapia para o câncer 
apesar de não haver consenso.  Objetivo: Este estudo objetivou estabelecer por meio de uma revisão da literatura a 
associação entre a microbiota bucal e a mucosite oral durante a Terapia para o Câncer de Cabeça e Pescoço (TCCP). 
Material e Métodos: Foi realizada uma busca na base de dados PubMed no período de 2008-2018 utilizando-se as 
palavras chave “oral mucositis” e “oral microbiota” nos subtítulos “etiology” e “microbiology” do descritor “Head and 
Neck Neoplasms” da base Medical Subject Heading (MeSH). A questão norteadora do estudo foi: “Ocorre uma disbiose 
durante a terapia para o câncer de cabeça e pescoço que esteja associada à mucosite oral?” Resultados: 22 artigos 
foram selecionados em duas etapas de extração dos dados: artigos que avaliaram a microbiota bucal durante TCCP 
(n=13), e artigos que também focaram na mucosite oral (n=9). Conclusão: A evidência apresentada na literatura 
sugere associação de uma disbiose da microbiota bucal com a progressão e agravamento da mucosite oral induzida 
pela radiação. Entretanto, novos estudos padronizados são necessários para se definir o core microbiano para a doença.
Palavras-chave: Estomatite; Microbiota Bucal; Neoplasias de Cabeça e Pescoço.
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INTRODUCTION
Chemotherapy (CT) and radiotherapy (RT) 
treatments are commonly used in cancer therapy. 
However, the agents used in these antitumor treatments 
do not discern healthy cell from disorderly grown 
cell. Therefore, the side effects to these therapies are 
recurrent and worrying to the patient health, being oral 
mucositis (OM) the most common side effect to the 
antitumor treatment of the head and neck region.1,2 
The establishment of OM is related to a cascade 
of impactful events for the patient and the community, 
raising the costs of cancer treatment and the mortality.1,3 
Its development ranges from increasing number of pro-
inflammatory cytokine receptors to damage of affected 
tissues by cell apoptosis and necrosis.4 Its symptoms 
of pain, difficulty in swallowing, trismus and decreased 
taste, detract from the nutrition of the patient, therefore, 
the predisposition to microbial virulence factors is 
greater, compromising the general state of health.1,5 
In fact, the oral microbiota has been implicated as an 
agent of progression and/or aggravation of the OM for 
years.3,6-7
Despite there are no effective interventions for 
OM therapy yet,8 the knowledge of the oral microbiota 
of individuals at head and neck cancer therapy could be 
the first step to comprehend its role in the development 
and progression of the OM disease. Therefore, the aim 
of this study was to determine, through a review, the 
association between oral microbiota and OM at head and 
neck cancer therapy (HNC).
MATERIAL AND METHODS
The key question to conduct this review was “Is 
there an oral dysbiosis during HNC therapy associated 
with OM?”. To answer the key question, a literature 
search of PubMed was carried out. The Medical 
Subject Heading (MeSH) “Head and Neck Neoplasms” 
with the subheadings etiology and microbiology, in 
combinations with the descriptors “oral mucositis” and 
“oral microbiota” were used. To restrict the results, the 
search was limited to studies published from 2008 up 
to 2018, with full text available and with analysis in 
humans. Case reports, experimental studies, review 
articles and letters to the editor were excluded.
RESULTS
The PubMed database is a reference database 
for the scientific literature including the health field. It 
contains more than 29 million references from MEDLINE, 
life science journals, and online books.9 Considering 
only MEDLINE, it comprises scientific journal articles 
from over 70 countries around the world being every 
day updated.10 
Regarding the search terms used and their 
associations, several articles were retrieved, which 
were selected considering the flow process presented 
in figure 1. At the end of the process, 22 articles 
were selected, nine of them specifically worked with 
oral microbiota analysis during head and neck cancer 
treatment focusing in OM. 
The 22 articles included in this review met 
the eligibility criteria, were identified to respond to 
the objective of the study and presented adequate 
          Figure 1: Flow diagram showing the retrieval process of studies included in the review.
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methodological relevance and quality. However, the 
process of data extraction were divided on two steps: 
first were analyzed the articles that evaluated oral 
microbiota during the head and neck cancer treatment 
(n=13), and then the articles that also focused in OM 
(n=9). These nine articles, named as “OM articles”, were 
studied and a synthesis of the literature was performed 
with the data extracted summarized in table 1. 
The sample size of the OM articles was quite 
similar, having the sample ranging from 19 to 49 
patients. However, the age of the study group was very 
different, with some of them working with age up to 
18 years,11 and other from 18 years.3 Furthermore, five 
studies are from countries of the European continent, 
among them Sweden,11,12 Croatia,13 Spain and Italy.3,14 
Three studies are from Asian countries, among them 
India,15 China and Japan.1,2,16 In addition, one study is 
from the American continent, more specifically Brazil.5 
The microbial analysis of OM articles
The studies selected had used different 
methodologies, both those of conventional culture 
with the microorganisms being analyzed by cultures 
in selective media,3,5,12-15 as microbial analysis by 16S 
sequencing.1,2,11 Six studies have analyzed bacteria and 
two studies analyzed mainly fungi.1-3,11-15  One study 
analyzed both microbiological groups.5
The kind of sample of OM articles
From the nine manuscript selected, three studies 
collected the sample with oropharyngeal swab before 
and after RT.2,13,15 One study collected the supragingival 
plaque before and after CT.14 One study collected the 
supra and subgingival plaque before and after RT.5 One 
study performed the injury swab before and during RT.1 
One study performed mucosal smear before, during and 
after RT.3 One study used strips of paper placed on the 
mucosa or OM if occurred.11 And one study used the 
mucosal swab and scraped the dorsum tongue during 
the treatment.12
 Considering the above, some distinct shifts 
were expected when comparing the manuscripts studied, 
because the sample region was distinct. However, the 
divergence of the manuscript goes beyond of the local 
of sample. It includes the RT and/or CT protocol, age of 
the cases studied, sampling time and microbial analysis 
type, which varied very much as described above in the 
results section and summarized in table 1.
DISCUSSION
In the mouth region the representativeness of 
the different microorganisms varies according to their 
different sites. This depends on specific characteristics 
such as nutrient availability, oxidation reduction 
potential, pH, contact with saliva, access to host defense 
molecules, and others.16 In the oral microbiota of healthy 
individuals the predominant groups in the mucosa are 
Streptococcus and Haemophilus, in supra and subgingival 
biofilms are Actinomyces and Prevotella, respectively.3,18 
In the gingival sulcus, there is predominant colonization 
of obligate anaerobes, besides Prevotella, also stand 
out Veillonella, Corynebacterium, Fusobacteriumand 
Rothia.4 In the lips we can find facultative anaerobes 
like Streptococcus and in smaller quantity Veillonella, 
Neisseria and Candida. In the cheeks and tongue, we 
find Streptococcus, Actinomyces and Haemophillus.4 The 
microorganisms found in saliva come from other sites 
of the mouth region, not being considered as having 
a resident microbiota.16 Other microorganisms besides 
bacteria can also be found frequently in the oral cavity, 
such as yeasts of the genus Candida.19
The microbiota has important functions for 
the host. Among these functions can be mentioned: 
auxiliary of human being to synthesis compounds that 
degrade toxic products, immune system modulating 
and serving as a barrier against pathogens colonization 
by inhibitory substancesproduction.5 However, when 
in disequilibrium with the host, this same microbiota, 
due to its great diversity and virulence potential, can 
become pathogenic by its amphibiotic character.2,5 
Therefore, resident microorganisms have the ability to 
live in harmony with the host, but eventually, due to 
some imbalance factor, are able to change the virulence 
factors expression presenting the aggression capacity. 
Furthermore, this change in the microbiota, called 
dysbiosis, is correlated with a higher risk of developing 
several diseases, including OM, since it may deregulate 
the immune system responses.5,20
Neoplasm, as well as their cytotoxic therapies, 
leads to a myelosuppression in which bone marrow 
activity is decreased. Thus, the defense system cells 
production of the individual being treated for cancer is 
reduced.4 The myelosuppression state may influence the 
diversity of the microbiome,21-23 and distinct antitumor 
treatments result in different oral microbiome changes 
but in a specific manner in each host.24-25 In the surgical 
treatment, the prevalence of T. forsythia tended to 
decrease.24 The RT induces changes in the oral microbiota 
and this is significantly different when associated 
with the mutational changes of the cancer,1,5,22,23,26 
changing progressively with tumor progression.23,27 
In the treatments of RT with or without adjuvant CT, 
there is an increase of bacteria from some groups 
including Proteobacteria, Spirochaetes,2,28 Treponema, 
Granulicatella, Capnocytophaga,2 Pseudomonas,1,2 
Pediococcus, Oscillibacter,1 Actinobacteria, 
Bacteroidetes, Firmicutes, Fusobacteria, TM7,28 C. 
albicans, C. tropicallisand C. Parapsilosis,15,29 and a 
decrease of Fusobacteria, Prevotella, Leptotrichiaand 
Campylobacter with increased radiation.1,2 Schuurhuis et 
al24 related that A. actinomycetemcomitans, P. gingivalis, 
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Table 1: Characteristics of oral mucositis articles. 
Author 
(year)
Samplepopulation Study design Main results Conclusion
Ognjenović M, 
Milatić K, Parat 
K, Kovacić I, 
Buselić Ma, 
Bozić J12
Cases: 25 patients with 
head and neck cancer 
treated with surgery 
and RT. The irradiation 
dose was 6000 cGy in 30 
separate doses of 200 cGy 
each.
Study type: longitudinal
Age: 47 to 84 years.
Sample: oral swabs
Sampling time: before, during 
the second week and after 3 
weeks after the end of irradiation. 
Microbial Analysis: Fungal 
culture in selective medium 
•	 Before irradiation: 80% negative and 20% pos-
itive patients (16% C. albicans, 4%C. krusei).
•	 Second week of irradiation: 64% negative and 
36% positive patients (5 species: C. albicans, C. 
glabrata, C. parapsilosis, Saccharomyces cerevi-
siae and C. guilliermondii).
•	 3 weeks after irradiation: 80% negative and 
20% positive patients (2 species: 16% C. albi-
cans and 4% C. Krusei).
•	 Oral mucositis degree increased simultaneously 
with increasing numbers of oral yeast species in 
positive patients.
•	 The Candida occur-
rence is statistically associ-
ated with mucositis.
•	 Mucositis appeared 
more frequently during RT, 
with increased positive iso-
lation of yeast species.
Ye Y, Carlsson 
G, Agholme 
MB, Wilson 
JA, Roos A, 
Henriques-
Normark B et 
al10
Cases: 37 patients 
with recent diagnosis of 
malignancies
Control group: n=38
Study type: longitudinal 
cohort
Age:4 and 18 years.
Sample: paper strips of oral 
mucosa
Sampling time: first at the time 
of diagnosis and during the CT 
prior to any sign of OM. Patients 
in whom MO occurred, samples 
of mucositis were collected using 
strips of paper placed on the top 
of the lesion
Microbial analysis: 16S 
sequencing 
•	 Microbial diversity during CT did not change sig-
nificantly compared to before CT, both for pa-
tients who developed OM (p0.11) and those who 
did not (p0,67).
•	 The patients who later development of OM are 
more heterogeneous among one another and 
showed higher microbial diversity at the time of 
diagnosis of malignancy.
•	 A more pronounced modification of the bacte-
rial community by CT was detected with subse-
quently development of OM
•	 Mucosal oral micro-
bial stability may be benefi-
cial in the OM course.
Vidal-
Casariego A, 
Fernández-
Natal I, 
Calleja-
Fernández A, 
Parras-Padilla 
T, Cano-
Rodríguez I, 
Prieto-Alonso 
B et al3
Cases: 35 patients with 
head and neck cancer 
treated under RT.
Study type: cohort
Age: >18 years.
Sample: Mucosa smear
Sampling time: before RT, in 
the middle of the RT period, and 
after RT termination.
Microbial analysis: bacterial 
and fungal culture research 
in selective media aerobic 
incubated.
•	 OM was more frequent in patients undergo-
ing RT. Bacteria and yeast were found in the study. 
•	 A positive correlation between severe muco-
sitis and bacterial cultures before RT was detected.
•	 The oropharingeal 
isolation of bacterial patho-
gens may favor the devel-
opment of severe OM during 
radiation therapy.
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Vozza,  
Caldarazzo, 
Ottolengh15 
Cases: 30 patients with 
solid malignancy, divided 
into 2 groups, which 
received CT (docetaxel 
or 5-fluorouracil and 
oxaliplatin) or not.
Study type: cohort
Age: 32 to 59 years.
Sample: supragingival plaque of 
the right lower premolars 
Sampling time: before CT, 1 
day after CT and 7 days after CT. 
Control subjects were sampled 
on equivalent dates.
Microbial analysis: bacterial 
culture research in selective 
media anaerobically and 
microaerobically incubated.
•	 OM developed in 66.6% patients in CT group 
and 0% in the control group. 
•	 No significant differences were found in bac-
terial alterations between tree times of sampling in 
CT group. 
•	 In the control group, the bacterial count re-
mained unchanged during the observation period. 
•	 There are no mi-
crobial changes in dental 
plaque in patients within 7 
days of the first CT cycle.
•	 The correlation be-
tween OM and specific mi-
croorganisms was not eval-
uated.
Singh GK, 
Capoor 
MR, Nair D, 
Bhowmik KT14
Cases: 49 patients with 
squamous cell carcinoma 
treated with RT and CT 
(cisplatin)
Study type: cohort
Age: 23 to 65 years.
Sample: Throat swab
Sampling time: before RT, 
during (2nd and 6th week) and 
post-radiotherapy (10th week).
Microbial analysis: Fungal 
culture in selective medium.
•	 27 samples was positive for Candida species: 
Non-albicans (36.73%)and Candida albicans 
(18.36%). 
•	 Higher rate of oral fungal colonization and in-
fection was found in patients with grade III and 
IV OM.
•	 Emergence of 
Non-albicans Candida war-
rants an early diagnosis and 
appropriate management. 
Zhu XX, Yang 
XJ, Chao YL, 
Zheng HM, 
Sheng HF, Liu 
HY et al1
Cases: 41 patients with 
nasopharyngeal cancer 
undergoing three-
dimensional conformal RT, 
associated or not with CT 
compared to the control 
group.
Control group: n=49
Study type: cohort
Age: 34 to 60 years.
Sample: Mucosal swab of the 
mucositis lesion region or the 
retropharyngeal region when 
they did not present lesions
Sampling time: prior to 
irradiation, after the 5th, 10th, 
15th, 20th, 25th, 30th and 35th 
radiation.
Microbial analysis: 16S 
sequencing 
•	 Individuals with nasopharyngeal carcino-
ma harbor significantly more Pseudomonas, Pedio-
coccus, Oscillibacter than healthy individuals. Rela-
tive abundances of nine genera: Phenylobacterium, 
Acinetobacter, Burkholderia, Sphingomonas, Azospi-
rillum, Rhizobium, Hydrogenophaga, Paracoccus and 
Nocardioides were significantly positively associated 
with an increase in RTOG (Radiation Oncology Group 
Criteria), while two genera Leptotrichia and Peptost-
reptococcus were significantly negatively associated 
with it
•	 Changes in oral mi-
crobiota correlate with the 
progression and aggravation 
of OM induced by RT.
Almståhl A, 
Finizia C, 
Carlen A, 
Fagerberg-
Mohlin B, 
Alstad T11
Cases: 33 Patients with 
head and neck cancer 
received bilateral curative 
RT. CT was generally given 
as 2 cycles of cisplatin and 
5-fluorouracil.
Study type: cohort
Age: 51 to 67 years.
Sample: Scraped dorsum tongue 
and bilateral mucosal swab.
Sampling time: During 
treatment, 6 months, 1 year and 
2 years post-treatment
Microbial analysis: 
bacterial culture research in 
selective media anaerobically, 
microaerobically and aerobically 
incubated.
•	 On the tongue: streptococci and Neisseria 
was decrease, whereas lactobacilli and C. albicans 
increased during treatment. Two years post-treat-
ment, Neisseria and Prevotella still low and Candida 
remain high.
•	  On the mucosa: lactobacilli and Staphylo-
coccus aureus increased during treatment. Two years 
post treatment the total count as well as streptococ-
ci, Neisseria and Fusobacterium nucleatum were de-
creased and lactobacilli increased. 
•	 70% showed severe OM during treatment.
The RT in the jead and neck 
region changes the oral 
microbiota, increasing the 
risk of mucosal infections.
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Gaetti-
Jardim Jr. E, 
Jardim ECG, 
Schweitzer 
CM, Silva JCF, 
Oliveira MM, 
Masocatto DC 
et al5
Cases: 28 patients with 
head and neck cancer 
of primary lesion under 
treatment of RT.
Control group: n=28
Study type: case-control
Age:18 to 68 years.
Sample: Supra and subgingival 
plaque. 
Sampling time: before RT, 
15-22 days after RT initiation, 
immediately after and 6 months 
after RT.
Microbial analysis: bacterial 
culture research in selective 
media anaerobically and 
aerobically incubated.
•	 The severity of OM is related to the presence 
of xerostomia, candidiasis, precarious oral hygiene, 
absence of previous dental treatment and predomi-
nance of supra and subgingival colonization by rep-
resentatives of the family Enterobacteriaceae and 
genus Candida.
•	 Positive correlation 
of enteric bacilli with severe 
OM.
•	 RT induces signifi-
cant changes in the oral mi-
crobiota, with predominance 
of Enterobacteriaceae and 
Candida species.
Hou J, Zheng 
H, Li P, Liu H, 
Zhou H, Yang 
X2
Cases:19 patients with 
nasopharyngeal cancer 
(all received RT and 16 of 
them also received CT)
Study type: cohort
Age:35 to 57 years.
Sample: Oropharynx swabbing
Sampling time: before 
irradiation and after 10, 20, 30, 
40, 50, 60 and 70 Gy sections of 
RT.
Microbial analysis: 16S 
sequencing
•	 The phyla Proteobacteria and Spirochaetes 
showed a tendency to increase, while Fusobacteria 
showed a decrease. 
•	 An increase of Fusobacterium, Treponema, 
Porphyromonas, and Prevotella are associated with 
aggravation of OM.
•	 A dysbiosis in the 
oral microbiota exacerbates 
the severity of OM. 
•	 Periodontal patho-
gens are associated with 
OM.
•	 Gram-negative rods 
are associated with higher 
degrees of OM.
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P. intermedia, T. forsythia, P. micra, F. nucleatum, C. 
rectus and S. mutans decreases after RT initiation, while 
opportunistic pathogens such as Staphylococci, Enteric 
rods and Candida sp. tend to increase in prevalence. 
However, in general, oral microecological diversity 
decreases as the dose of radiation increases, but it rises 
again over time after RT treatment.28 
Other factors also contribute to microbial 
dysbiosis during the head and neck cancer treatment. 
Xerostomia, for example, another oral manifestation 
resulting from damage caused to the salivary glands 
by treatments with CT and RT, also contributes to 
microbial dysbiosis and development of opportunistic 
pathogens. The damage to salivary glands leads to 
reduction of salivary flow, and saliva in turn, has 
enzymes and antibodies important for the control of the 
oral microbiota.5  These damages may be irreversible30, 
definitively altering the resident microbiota. Small doses 
of radiation are able to alter the volume and composition 
of saliva. Moreover, the severity of the xerostomia is 
correlated with the radiation dose used.31 Saliva 
contains antimicrobial substances such as lysozyme and 
immunoglobulin. Changes in saliva due to CT and RT can 
influence the health/integrity of the mucosa making it 
more susceptible to microorganisms.5 
Although the researchers looked for the 
microorganisms involved in the occurrence of OM, 
the correlation between specific microorganism and 
OM severity degree began only recently.1,2,5 During RT 
treatment, bacterial colonization of the oropharynx may 
favor the development of severe OM being the Gram-
negative bacteria and enteric bacilli associated with 
higher degrees of MO.3,2,5 The increase in the number 
of species of oral yeasts, is also related to the OM 
aggravation which during the RT is associated with low 
lymphocytes.13,16 
OM affects patients commonly few days after 
initiation of CT or RT therapy. However, no significant 
microbiological changes occur in the first 7 days of CT.14 
The signs of OM are due to an inflammatory process 
in the mucosa, which may lead to ulceration, and 
consequently to odynophagia, dysgeusia, dysphagia or 
discomfort,5 symptoms very impacting to the individual 
general health that can lead to cancer treatment 
interruption. The inflammatory characteristics of OM 
and the immune defense suppression are important 
for the microbial ecosystem imbalance of the mouth 
and this dysbiosis may exacerbate the severity of this 
inflammation.5,1,2,11,15 These factors, together with the 
ulcerations generated in OM, serve as gateways for a 
greater number of pathogenic microorganisms,12 as 
the periodontopathogens that are strongly found in the 
mouth cancer and are associated with OM.27,2
Considering fungal colonization, it begins to 
increase during the second week of CT and its apogee 
takes place during the sixth week.29 When systemic 
opportunistic infections are detected, the identification 
of the causative agents and their susceptibility will 
allow the early identification of the treatment options.19 
According to Singh et al14, the use of prophylactic 
Fluconazole in patients under treatment with RT and CT 
has the potential to reduce the morbidity associated with 
OM. Considering RT, after the end of this therapy, there 
was a decrease in the number of patients presenting 
any type of Candida,29 but the degree of OM increases 
simultaneously with the increase of oral yeasts species 
during RT.13 The most prevalent yeasts are C. albicans, 
C. tropicalis, C. parapsilosis, C. krusei, C. subliniensis 
and S. cerevisiae.19 In addition, the total RT dose, the 
RT method, the OM and the minimal lymphocyte count 
during RT are significantly associated with the incidence 
of oral candidiasis.16
A variation of the bacterial composition during 
the CT is more evident in patients who develop the MO,11 
while OM is more present in patients who undergo radical 
RT treatment.3 The bacterial colonization of patients who 
have mouth cancer, are predominant in phyla Firmicutes, 
Bacteroidetes, Actinobacterias,23,27 Proteobacteria,22,23,27 
and Actinobacteria.27 According to Schmidt et al21 occurs 
a significant reduction of Firmicutes and Actinobacteria 
in cancerous regions when compared to anatomically 
normal regions. The most prevalent genera are 
Streptococcus, Prevotella,23,26,27 Neisseria,23,25,27 
Veitonella,23,26 Fusobacteria, Haemophilus and 
Porphyromonas.27,26 The Actinobacteria, besides being 
related to CA is also related to potentially malignant 
lesions (PML).22-23,27 On the other hand, the genera 
of bacteria most associated with OM aggravation 
are Fusobacteria, Treponema, Porphyromonas, 
Prevotella,2 Phenylobacterium, Acinetobacter, 
Bukholderia, Sphingomonas, Azospirillum, Rhizobium, 
Hydrogenophaga, Paracoccusand Nocardioides, while 
the genera Leptotrichia and Peptostreptococcusare 
negatively related to the increase in severity of OM.1 
The most severe cases of OM have a tendency of a 
greater growth of Neisseria in the tongue and a decrease 
of growth of Prevotella, S. Aureus, Candida and Gram-
negative.12 Furthermore OM severity is related to 
xerostomia, candidiasis, poor hygiene, absence of 
previous dental treatment,5 sub- and supragingival 
colonization of Enterobacteriaceae and Candida.5,12 
It is known that RT and/or CT treatment 
leads to alteration in the oral microbiota, favoring the 
development of MO. Studies that correlate microbiota 
and OM are important to consider treatment possibilities 
since changes in the oral microbiota are significant and 
may impair the patient’s health status. However, for the 
complete understanding of the processes involved in 
the development and progression of OM, other aspects 
such as the differences between the chemotherapeutics 
and doses of radiotherapy used, among others, should 
be considered. Therefore, it is extremely relevant to 
take care of the patient oral health prior to the start of 
antineoplastic therapy. 
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CONCLUSIONS
From the reviewed literature, it has been 
scientifically proven that changes in the oral microbiota 
are correlated with the progression and worsening of 
radiation-induced OM. However the microbial core for 
the disease has not yet been defined, since there is 
no consensus on sample type methodologies, time of 
therapy, patient characteristics, among others.
ACKNOWLEDGEMENTS
The authors thank the LABINT-UFJF by english 
revision.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of 
interest to disclose. 
REFERENCES
1. Zhu XX, Yang XJ, Chao YL, Zheng HM, Sheng HF, Liu HY et 
al. The potential effect of oral microbiota in the prediction of 
mucositis during radiotherapy for nasopharyngeal carcinoma. 
EBioMedicine. 2017; 18:23-31.
2. Hou J, Zheng H, Li P, Liu H, Zhou H, Yang X. Distinct shifts 
in the oral microbiota are associated with the progression and 
aggravation of mucositis during radiotherapy. Radiother Oncol. 
2018; 129(1):44-51.
3. Vidal-Casariego A, Fernández-Natal I, Calleja-Fernández 
A, Parras-Padilla T, Cano-Rodríguez I, Prieto-Alonso B et al. 
Nutritional, microbiological, and therapeutic factors related to 
mucositis in head and neck cancer patients: a cohort study. 
Nutr Hosp. 2015; 32:1208-13.
4. Stringer AM, Logan RM. The role of oral flora in the 
development of chemotherapy-induced oral mucositis. J Oral 
Pathol Med. 2015; 44(2):81-7.
5. Gaetti-Jardim Jr. E, Jardim ECG, Schweitzer CM, Silva 
JCF, Oliveira MM, Masocatto DC et al. Supragingival and 
subgingivalmicrobiota from patients with poor oral hygiene 
submitted to radiotherapy for head and neck cancer 
treatment. Arch Oral Biol. 2018; 90:45-52. doi: 10.1016/j.
archoralbio.2018.01.003.
6. Hu YJ, Shao ZY, Wang Q, Jiang YT, Ma R, Tang ZS et al. 
Exploring the dynamic core microbiome of plaque microbiota 
during headand-neck radiotherapy using pyrosequencing. PLoS 
One. 2013; 8(2):e56343.
7. Vanhoecke B, Ryck T, Stringer A, Van De Wiele T, Keefe D. 
Microbiota and their role in the pathogenesis of oral mucositis. 
Oral Dis. 2015; 21(1):17-30.
8. Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral 
mucositis. Front Oncol. 2017; 7:89.
9. MEDLINE [Internet]. Wikipédia: a enciclopédia livre. 2018. 
[citado em 2019 Feb 11]. Disponível em: https://pt.wikipedia.
org/wiki/MEDLINE.
10. Ye Y, Carlsson G, Agholme MB, Wilson JA, Roos A, Henriques-
Normark B et al. Oral bacterial community dynamics in paediatric 
patients with malignancies in relation to chemotherapy-related 
oral mucositis: a prospective study. Clin Microbiol Infect. 2013; 
19(12):e559-67.
11. Almståhl A, Finizia C, Carlen A, Fagerberg-Mohlin B, Alstad 
T. Mucosal microflora in head and neck cancer patients. Int J 
Dent Hyg. 2018; 16(4):459-66.
12. Ognjenović M, Milatić K, Parat K, Kovacić I, Buselić Ma, 
Bozić J. Mucositis grades and yeast species. Coll Antropol. 
2013; 37(2):443-7.
13. Vozza I, Caldarazzo V, Ottolenghi L. Changes in microflora in 
dental plaque from cancer patients undergoing chemotherapy 
and the relationship of these changes with mucositis: a pilot 
study. Med Oral Patol Oral Cir Bucal. 2015; 20(3):e259-66.
14. Singh GK, Capoor MR, Nair D, Bhowmik KT.  Spectrum 
of fungal infection in head and neck cancer patients on 
chemoradiotherapy. J Egypt Natl Canc Inst. 2017; 29(1):33-7.
15. Kawashita Y, Funahara M, Yoshimatsu M, Nakao N, Soutome 
S, Saito T et al. A retrospective study of factors associated 
with the development of oral candidiasis in patients receiving 
radiotherapy for head and neck cancer: is topical steroid 
therapy a risk factor for oral candidiasis? Medicine (Baltimore). 
2018; 97(44):13073.
16. Marsh P, Martin MV, Lewis MAO. Oral microbiology. London: 
Elsevier; 2009.
17. The Human Microbiome Project Consortium. Structure, 
function and diversity of the healthy human microbiome. 
Nature. 2012; 468(7402):207-14.
18. Bulacio L, Paz M, Ramadán S, Ramos L, Pairoba C, Sortino 
M et al. Oral infections caused by yeasts in patients with head 
and neck cancer undergoing radiotherapy: identification of the 
yeasts and evaluation of their antifungal susceptibility. J Mycol 
Med. 2012; 22(4):348-53.
19. Tomkovich S, Jobin C. Microbiota and host immune 
responses: a love-hate relationship. Immunology. 2016; 
147(1):1-10.
20. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby 
Ribeiro l Or l microbiot  versus oral m cositis.
HU Rev. 2020; 46:1-9. DOI: 10.34019/1982-8047.2020.v46.28995
HU rev. 2019; 45(1):13-21. DOI: 10.34019/1982-8047.2019.v45.16970
Pinhati et al. Health literacy and blood pressure control
9
PM, Queiroz EL  et al. Changes in abundance of oral microbiota 
associated with oral cancer. PLoS One. 2014; 9(6):e98741.
21. Mok SF, Karuthan C, Cheah Yk, Ngeow WC, Rosnah Z, Yap 
SF et al. The oral microbiome community variations associated 
with normal, potentially malignant disorders and malignant 
lesions of the oral cavity. Malays J Pathol. 2017; 39(1):1-15.
22. Yang CY, Yeh YM, Yu HY, Chin CY, Hsu CW, Liu H et al. Oral 
microbiota community dynamics associated with oral squamous 
cell carcinoma. Front Microbiol. 2018; 9:862.
23. Schuurhuis JM, Stokman MA, Witjes MJ, Langendijk JA, van 
Winkelhoff AJ, Vissink A et al. Head and neck intensity modulated 
radiation therapy leads to an increase of opportunistic oral 
pathogens. Oral Oncol. 2016; 58:32-40.
24. Xu Y,  Teng F,  Huang S, Lin Z, Yuan X, Zeng X et 
al. Changes of saliva microbiota innasopharyngeal carcinoma 
patients under chemoradiation therapy. Arch Oral Biol. 2014; 
59(2):176-86.
25. Chen X, Winckler B, Lu M, Zhang Y, Jin L, Ye W. Poor oral 
health is associated with an increased risk of esophageal 
squamous cell carcinoma: a population-based case-control 
study in China. Int J Cancer. 2015; 140(3):626-35.
26. Zhao H, Chu M, Huang Z, Yang X,Ran S, Hu B et al. 
Variations in oral microbiota associated with oral cancer. Sci 
Rep. 2017; 7(1):11773.
27. Gao L, Hu Y, Wang Y, Jiang W, He Z, Zhu C et al. 
Exploring the variation of oral microbiota insupragingival 
plaque during and after head-and-neck radiotherapy using 
pyrosequencing. Arch Oral Biol. 2015; 60(9):1222-30.
28. Raj S, Sharma D, Mate P, Capoor MR, Bhowmik KT. A study 
of changes in the oral fungal flora of patients on radiotherapy 
for head and neck malignancies and their correlation with 
funguria and fungemia. Indian J Cancer. 2017; 54(1):39-42.
29. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar 
PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to 
prevent fungal infections in patients undergoing bone marrow 
transplantation. N Engl J Med. 1992; 326(13):845-51.
31. Buglione M, Cavagnini R, Rosario F, Maddalo M, Vassali L, 
Grisanti S et al. Oral toxicity management in head and neck 
cancer patients treated with chemotherapy and radiation: 
xerostomia and trismus (part 2): literature review and 
consensus statement. Crit Rev Oncol Hematol. 2016; 102:47-
54.
32. Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B 
et al. Comparison of oral microbiota in tumor and non-tumor 
tissues of patients with oral squamous cell carcinoma. BMC 
Microbiol. 2012; 12:144. doi: 10.1186/1471-2180-12-144. 
33. Yang SF, Huang HD, Fan WL, Jong YJ, Chen MK, Huang CN 
et al. Compositional and functional variations of oral microbiota 
associated with the mutational changes in oral cancer. Oral 
Oncol. 2018; 77:1-8. doi: 10.1016/j.oraloncology.2017.12.005. 
Ribeiro et al. Oral microbiota versus oral mucositis.
HU Rev. 2020; 46:1-9. DOI: 10.34019/1982-8047.2020.v46.28995
